Inhibition of Protein Farnesylation Affects Fat Cell Development
Author Information
Author(s): Daniel Rivas, Akter Rahima, Gustavo Duque
Primary Institution: Lady Davis, Institute for Medical Research
Hypothesis
Protein farnesylation is required for PPARγ2 expression and activation, and therefore for the differentiation of human mesenchymal stem cells (MSCs) into adipocytes.
Conclusion
Inhibition of protein farnesylation arrests the adipogenic differentiation of MSCs and affects PPARγ expression and activity.
Supporting Evidence
- Inhibition of farnesylation led to changes in cell phenotype and reduced fat droplet production.
- Cells treated with the inhibitor showed nuclear changes compatible with blebbing.
- The study demonstrated that farnesylation is essential for the activation of proteins involved in adipogenesis.
Takeaway
This study found that blocking a specific process in cells stops them from turning into fat cells, which is important for understanding fat development in the body.
Methodology
Human MSCs were induced to differentiate into adipocytes and treated with a farnesylation inhibitor, with effects assessed through staining and protein expression analysis.
Limitations
Pharmacological inhibition of farnesylation could affect many proteins required in adipogenesis.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website